Botulinum Injections for Idiopathic Cervical Dystonia: a Longitudinal Study

Area of Science:

• Neurology
• Pharmacology

Background:

• Cervical dystonia (CD) is a movement disorder characterized by involuntary neck muscle contractions.
• Botulinum toxin (BT) injections are a primary treatment for CD, targeting specific muscles to alleviate symptoms.

Purpose of the Study:

• To evaluate the long-term efficacy and safety of repeated botulinum toxin (BT) injections in patients with idiopathic cervical dystonia (ICD).
• To analyze treatment patterns, including toxin type, dosage, and clinical outcomes over an extended period.

Main Methods:

• Retrospective longitudinal study analyzing electronic medical records of 64 ICD patients treated between 2008-2020.
• Data collected included toxin type (primarily abobotulinum toxin A), dosage, number of treatment visits, and reported clinical outcomes and side effects.

Main Results:

• BT treatment efficacy improved gradually, reaching a steady state by the 13th visit.
• Patients reported significant improvement (78.9%) lasting approximately 2.8 months, with a notable increase in BT dosage over time (p=0.006).
• Common side effects included dysphagia (17.5%), neck/arm weakness (11.9%), and cervical pain (8.9%), generally mild and transient.

Conclusions:

• Repeated BT injections provide sustained benefits for ICD patients over several years.
• Despite mild and manageable side effects, patients typically adhere to a 3-4 month injection schedule, highlighting the treatment's long-term value.